Zyrop 4000 IU Injection Erythropoietin Alfa

Zyrop 4000 IU Injection contains erythropoietin alfa, a recombinant human erythropoietin used in the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy, and other chronic conditions. It helps stimulate red blood cell production, improving oxygen delivery and reducing symptoms like fatigue and weakness.

This injection is widely used in nephrology and oncology to maintain stable hemoglobin levels and reduce the need for blood transfusions.

How it works

Erythropoietin alfa mimics the natural hormone produced by the kidneys. It stimulates the bone marrow to produce red blood cells, helping restore normal oxygen levels in the body.

• Anemia due to chronic kidney disease (CKD)
• Chemotherapy-induced anemia
• Anemia in chronic illnesses

Benefits

• Promotes red blood cell production
• Improves hemoglobin levels
• Reduces fatigue and weakness
• Helps decrease transfusion requirements

Administered via subcutaneous or intravenous injection. Dosage depends on hemoglobin levels and patient response. Use under medical supervision.